Enhanced Recovery after Surgery (ERAS) Protocol Is a Safe and Effective Approach in Patients with Gastrointestinal Fistulas Undergoing Reconstruction: Results from a Prospective Study

Stanislaw Klek, Jerzy Salowka, Ryszard Choruz, Tomasz Cegielny, Joanna Welanyk, Mariusz Wilczek, Kinga Szczepanek, Magdalena Pisarska-Adamczyk, Michal Pedziwiatr, Stanislaw Klek, Jerzy Salowka, Ryszard Choruz, Tomasz Cegielny, Joanna Welanyk, Mariusz Wilczek, Kinga Szczepanek, Magdalena Pisarska-Adamczyk, Michal Pedziwiatr

Abstract

Background and aims: An enterocutaneous fistula (ECF) poses a major surgical problem. The definitive surgical repair of persistent fistulas remains a surgical challenge with a high rate of re-fistulation and mortality, and the reasons for that is not the surgical technique alone. Enhanced Recovery after Surgery (ERAS®) is an evidence-based multimodal perioperative protocol proven to reduce postoperative complications. The aim of the study was to assess the clinical value of the ERAS protocol in surgical patients with ECF.

Methods: ERAS protocol was used in all patients scheduled for surgery for ECF at the Stanley Dudrick's Memorial Hospital in Skawina between 2011 and 2020. A multidisciplinary team (MDT) was in charge of the program and performed annual audits. A consecutive series of 100 ECF patients (44 females, 56 males, mean age 54.1 years) were evaluated. Postoperative complications rate, readmission rate, length of hospital stay, prevalence of postoperative nausea and vomiting were assessed. Registered under ClinicalTrials.gov Identifier no. NCT04771832.

Results: ERAS protocol was successfully introduced for ECF surgeries; however, eight modifications to the ERAS program was performed in 2015. They led to improvement of surgical outcomes: reduction of postoperative nausea and vomiting (15 vs. 17% patients, p = 0.025), overall complication rate (11 vs. 10, p = 0.021), median length of hospital stay (overall and after surgery, p = 0.022 and 0.002, respectively).

Conclusions: ERAS protocol can be successfully used for ECF patients. Prescheduled audits can contribute to the improvement of care.

Keywords: ERAS; GI tract; gastrointestinal surgery; reconstruction.

Conflict of interest statement

S.K. received honoraria as a lecturer from Baxter, B Braun, Fresenius Kabi, Nestle, Nutricia and Shire/Takeda. K.S. received honoraria as a lecturer from Baxter, B Braun, Fresenius Kabi, Nestle, Nutricia. R.C. and M.P. received honoraria as a lecturer from Nestle and Nutricia. M.P.-A., J.S., T.C., J.W., M.W. declare no conflict of interest.

References

    1. Lynch A.C., Delaney C.P., Senagore A.J., Connor J.T., Remzi F.H., Fazio V.W. Clinical Outcome and Factors Predictive of Recurrence After Enterocutaneous Fistula Surgery. Ann. Surg. 2004;240:825–831. doi: 10.1097/01.sla.0000143895.17811.e3.
    1. Wainstein D.E., Fernandez E., Gonzalez D., Chara O., Berkowski D. Treatment of High-Output Enterocutaneous Fistulas with a Vacuum-Compaction Device. A Ten-year Experience. World J. Surg. 2008;32:429. doi: 10.1007/s00268-008-9508-x.
    1. European Commission Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on Or-Phan Medicinal Products. [(accessed on 10 March 2010)]; Available online: .
    1. Visschers R.G.J., Damink S.W.M.O., Winkens B., Soeters P.B., Van Gemert W.G. Treatment Strategies in 135 Consecutive Patients with Enterocutaneous Fistulas. World J. Surg. 2008;32:445–453. doi: 10.1007/s00268-007-9371-1.
    1. Kluciński A., Wroński M., Cebulski W., Guzel T., Witkowski B., Makiewicz M., Krajewski A., Słodkowski M. Surgical Repair of Small Bowel Fistulas: Risk Factors of Complications or Fistula Recurrence. Med. Sci. Monit. 2019;25:5445–5452. doi: 10.12659/MSM.914277.
    1. Klek S., Forbes A., Gabe S., Holst M., Wanten G., Irtun Ø., Damink S.O., Panisic-Sekeljic M., Pelaez R.B., Pironi L., et al. Management of Acute Intestinal Failure: A Position Paper from the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group. Clin Nutr. 2016;35:1209–1218. doi: 10.1016/j.clnu.2016.04.009.
    1. Hollington P., Mawdsley J., Lim W., Gabe S.M., Forbes A., Windsor A. An 11-year Experience of Enterocutaneous Fistula. Br. J. Surg. 2004;91:1646–1651. doi: 10.1002/bjs.4788.
    1. Martinez J.L., Luque-De-Leon E., Mier J., Blanco-Benavides R., Robledo F. Systematic Management of Postoperative Enterocutaneous Fistulas: Factors Related to Outcomes. World J. Surg. 2008;32:436–443. doi: 10.1007/s00268-007-9304-z.
    1. Gustafsson U.O., Scott M.J., Hubner M., Nygren J., Demartines N., Francis N., Rockall T.A., Young-Fadok T.M., Hill A.G., Soop M., et al. Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations: 2018. World J. Surg. 2019;43:659–695. doi: 10.1007/s00268-018-4844-y.
    1. Roesel R., Mongelli F., Ajani C., Iaquinandi F., Celio D., Christoforidis D. Bowel Function Recovery after Laparoscopic Transverse Colectomy within an ERAS Program: A Comparison to Right and Left Colectomy. Langenbeck’s Arch. Surg. 2021:1–8. doi: 10.1007/s00423-021-02082-3.
    1. Pędziwiatr M., Mavrikis J., Witowski J., Adamos A., Major P., Nowakowski M., Budzyński A. Current Status of Enhanced Recovery after Surgery (ERAS) Protocol in Gastrointestinal Surgery. Med. Oncol. 2018;35:95. doi: 10.1007/s12032-018-1153-0.
    1. Pędziwiatr M., Wierdak M., Nowakowski M., Pisarska M., Stanek M., Kisielewski M., Matłok M., Major P., Kłek S., Budzynski A. Cost Minimization Analysis of Laparoscopic Surgery for Colorectal Cancer within the Enhanced Recovery after Surgery (ERAS) Protocol: A Single-Centre, Case-Matched Study. Videosurg. Other Miniinvasive Tech. 2016;11:14–21. doi: 10.5114/wiitm.2016.58617.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit